QIAGEN(US:QGEN) ZACKSยท2025-06-04 14:50Core Insights - Zacks Premium offers various tools for investors to enhance their stock market strategies and confidence [1] - The Zacks Style Scores are designed to help investors select stocks with the highest potential to outperform the market in the short term [2] Zacks Style Scores Overview - The Style Scores consist of four categories: Value Score, Growth Score, Momentum Score, and VGM Score, each targeting different investment strategies [3][4][5][6] - Value Score focuses on identifying undervalued stocks using financial ratios [3] - Growth Score assesses a company's future earnings and financial health to find sustainable growth opportunities [4] - Momentum Score capitalizes on price trends and earnings outlook changes to identify favorable buying times [5] - VGM Score combines all three styles to highlight stocks with the best overall potential [6] Zacks Rank and Style Scores Interaction - The Zacks Rank is a proprietary model that uses earnings estimate revisions to simplify portfolio building [7] - Stocks rated 1 (Strong Buy) have historically achieved an average annual return of +25.41% since 1988, significantly outperforming the S&P 500 [8] - To maximize returns, investors should focus on stocks with a Zacks Rank of 1 or 2 and Style Scores of A or B [9] - Stocks with lower ranks (4 or 5) may still have high Style Scores but are likely to face declining earnings forecasts [10] Company Spotlight: Qiagen (QGEN) - Qiagen N.V. is a leading provider of technologies for nucleic acid separation and purification, with a portfolio of over 500 proprietary products [11] - Qiagen holds a Zacks Rank of 2 (Buy) and a VGM Score of A, indicating strong growth potential [12] - The company is forecasted to achieve a year-over-year earnings growth of 6.9% for the current fiscal year, with upward revisions from analysts [12] - Qiagen's average earnings surprise stands at 4.9%, making it a strong candidate for growth investors [12][13]